Coherus Oncology Inc (CHRS)

May 05, 2026

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year? - Yahoo! Finance Canada

May 05, 2026

May 04, 2026

Coherus Oncology (CHRS) to Release Q1 2026 Financial Results - GuruFocus

May 04, 2026

May 04, 2026

Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - The Manila Times

May 04, 2026

May 04, 2026

Coherus sets May 11 after-close call for Q1 results, business update - Stock Titan

May 04, 2026

May 02, 2026

Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat

May 02, 2026

Apr 30, 2026

Hepatic Tumor Pipeline Grows as 75+ Pharma Companies Advance - openPR.com

Apr 30, 2026

Apr 29, 2026

Satterfield reports 6.93M shares in Coherus Oncology (NASDAQ: CHRS) ownership filing - Stock Titan

Apr 29, 2026

Apr 27, 2026

BlackRock reports 4.9% stake in Coherus Oncology (CHRS) - Stock Titan

Apr 27, 2026

Apr 26, 2026

Coherus Oncology announces proposed public offering of common stock - MSN

Apr 26, 2026

Apr 24, 2026

Coherus Oncology (NASDAQ:CHRS) Share Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat

Apr 24, 2026

Apr 24, 2026

CHRS Price Today: Coherus Oncology, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 23, 2026

Coherus Oncology prices stock offering to raise $50.1M - MSN

Apr 23, 2026

Apr 20, 2026

Is Coherus (CHRS) stock losing upward momentum (Bullish Sentiment) 2026-04-20Crowd Sentiment Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 20, 2026

[ARS] Coherus Oncology, Inc. SEC Filing - Stock Titan

Apr 20, 2026

Apr 20, 2026

[DEF 14A] Coherus Oncology, Inc. Definitive Proxy Statement - Stock Titan

Apr 20, 2026

Apr 16, 2026

Coherus (CHRS) Stock Signal Based Trade (Bullish Momentum) 2026-04-16Professional Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La

Apr 16, 2026

Apr 16, 2026

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 16, 2026

Apr 16, 2026

Coherus Oncology (NASDAQ:CHRS) Stock Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Apr 16, 2026

Apr 16, 2026

Coherus Oncology (CHRS) is one of the best penny stocks, here is why – corrected - MSN

Apr 16, 2026

Apr 16, 2026

Coherus Oncology Inc (STU:8C5) Stock Price & 30 Year Financial Data - GuruFocus

Apr 16, 2026

Apr 13, 2026

Certain Warrants of Coherus Oncology, Inc. are subject to a Lock-Up Agreement Ending on 14-APR-2026. - marketscreener.com

Apr 13, 2026

Apr 13, 2026

Certain Stock Options of Coherus Oncology, Inc. are subject to a Lock-Up Agreement Ending on 14-APR-2026. - marketscreener.com

Apr 13, 2026

Apr 13, 2026

Certain Common Stock of Coherus Oncology, Inc. are subject to a Lock-Up Agreement Ending on 14-APR-2026. - marketscreener.com

Apr 13, 2026

Apr 13, 2026

CHRS SEC FilingsCoherus 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 13, 2026

Apr 13, 2026

What should investors watch in Coherus (CHRS) Stock | Price at $1.66, Down 1.49%Trader Community Insights - Xã Vĩnh Công

Apr 13, 2026

Apr 10, 2026

Coherus Oncology (CHRS) Is One of the Best Penny Stocks, Here is Why – Corrected - Yahoo Finance

Apr 10, 2026

Apr 09, 2026

Coherus Oncology (CHRS) proposes option repricing and 7.7M-share increase - Stock Titan

Apr 09, 2026

Apr 07, 2026

Coherus Oncology Receives 'Hold' Rating from Analysts - National Today

Apr 07, 2026

Apr 07, 2026

Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Apr 07, 2026

Apr 02, 2026

Coherus Oncology (NASDAQ:CHRS) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat

Apr 02, 2026

Apr 01, 2026

Why The Coherus Oncology (CHRS) Story Is Shifting Around Growth Assumptions And Execution Risk - Yahoo Finance

Apr 01, 2026

Mar 27, 2026

Coherus Oncology (CHRS) upgraded to buy: Here's what you should know - msn.com

Mar 27, 2026

Mar 26, 2026

Vanguard disaggregates holdings; 0% stake in Coherus (NASDAQ: CHRS) - Stock Titan

Mar 26, 2026

Mar 26, 2026

If You Invested $1,000 in Coherus (CHRS) - Stock Titan

Mar 26, 2026

Mar 25, 2026

Metastatic Hepatocellular Carcinoma Clinical Trial Pipeline - openpr.com

Mar 25, 2026

Mar 25, 2026

Coherus Oncology (CHRS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Mar 25, 2026

Mar 24, 2026

Coherus Oncology (NASDAQ:CHRS) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Mar 24, 2026

Mar 19, 2026

Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 19, 2026

Mar 17, 2026

CHRS Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 17, 2026

Mar 16, 2026

Coherus BioSciences Q4 2025 earnings preview - MSN

Mar 16, 2026

Mar 16, 2026

Coherus Oncology (CHRS) Short Interest & Short Float | Updated Mar 2026 - MarketBeat

Mar 16, 2026

Mar 14, 2026

Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf. - MarketBeat

Mar 14, 2026

Mar 14, 2026

Coherus Oncology (NASDAQ:CHRS) Upgraded at Wall Street Zen - MarketBeat

Mar 14, 2026

Mar 13, 2026

Coherus Oncology, Inc. (NASDAQ:CHRS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Mar 13, 2026

Mar 11, 2026

Coherus Oncology (CHRS) price target increased by 13.33% to 5.78 - MSN

Mar 11, 2026